INTERACTIVE EVENT SUMMARY: Harnessing flow cytometry for high-throughput screening in immunotherapy development
20 January 2025
Poster
Spatial mapping: shaping the future of I-O diagnostics and treatment
Banafshé Larijani
06 December 2024
Interview
Enhancing CAR-T efficacy for targeting lymphoma and solid tumors
Ruchi Patel
03 December 2024
Watch
Navigating the opportunities and challenges in analytical development of flowcytometry for T cell therapy
Therese Choquette, Minh Ngoc Duong
25 November 2024
Innovator Insight
Emerging global trends and regulatory opportunities in cell therapies for cancer
Kim Watanabe, Sushama Sankpal, Kasey Kime
13 November 2024
Watch
Revolutionizing the treatment of cancer with allogeneic CAR-T cell therapy
Cokey Nguyen
13 November 2024
Expert Insight
Harnessing flow cytometry for high-throughput screening in immunotherapy development
Kevin Chen, Jonah Riddell, Raffaello Cimbro
12 November 2024
Watch
Assessing CAR-T cell therapy in vitro using patient-derived glioblastoma organoids
Meghan Logun
05 November 2024
Watch
Engineering lipid nanoparticles for lung cancer imaging
Ben Knappett, Blaine McCarthy
03 October 2024
Watch
Advancing cellular therapies: moving beyond the CAR-T landscape
Frank Borriello
05 September 2024
Interview
Cellular immunotherapy—a matter of delivery?
Nina Bauer
05 September 2024
Viewpoint
Challenges and innovations in patient selection, biomarkers, and personalized treatments within the I-O landscape
Oliver Rosen
04 September 2024
Interview
Patient-specific factors that could influence gene therapy outcomes in sickle cell disease
Abdulrahman Alsultan, Jaap Jan Boelens
02 September 2024
Expert Insight
Ex vivo engineering of hematopoietic stem cells using RNA-LNPs for cell and gene therapies
Reka Geczy
02 July 2024
Watch
Same-section spatial multiomics: a platform for detailed analysis of the solid TME
Emily Neil, Ariadna Pascual
27 June 2024
Watch
Navigating the EU joint clinical assessment process: key considerations for manufacturers of ATMPs and oncology medicines
Clare L Hague
18 June 2024
Commentary
Corrigendum to: Revolutionizing cancer treatment? A conversation on the potential of personalized cancer vaccines
Roy de Souza, David Hawke
30 May 2024
Corrigendum
Considerations to optimize and act upon long-term follow-up studies for cell and gene therapies
K Wonnacott, L Pelloso, D Takefman et al
11 April 2024
Watch
CAR-T manufacturing intensification: the next wave of CAR-T commercialization
A Bersenev, E Kleiren, J Knighton et al
09 April 2024
Watch
Exploring the potential of combination radio-immunotherapy for a comprehensive cancer treatment
Zachary Morris
04 April 2024
Viewpoint
Unraveling combination therapies in lung cancer: oncogenic drivers, ICI resistance, and predictive biomarkers
Paul Hofman
27 March 2024
Viewpoint